What is GMED's five-year median EV/EBITDA?

21.4x. Half of GMED's weekly readings over the last five years were higher and half were lower. This page has 712 weekly readings, from Mar 4, 2013 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares GMED only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Globus Medical Inc (GMED) valuation history

Health Care

$81.41

Latest weekly close · Market cap $11.2B

Historically low

As of Oct 24, 2026

GMED's EV/EBITDA of 11.5x is lower than 97% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 21.4×

5-year median: 21.4×
10-year median: 21.8×
5-year low to high: 10.4×–35.2×
Versus 5-year median: -46%

EV/EBITDA

3rdpercentile

of its weekly readings over the last five years

Historically low

Growth, last 12 months vs the year before

Revenue: +20%accelerating
EPS: +50%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

GMED EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	17.7×	21
Dec 30, 2024	28.8×	66
Dec 25, 2023	22.7×	40
Dec 26, 2022	27.4×	73
Dec 27, 2021	24.8×	69
Dec 28, 2020	37.7×	99
Dec 30, 2019	26.3×	99
Dec 31, 2018	17.4×	77
Dec 25, 2017	18.4×	99
Dec 26, 2016	10.6×	27

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare GMED with peers

Health Care peers of GMED on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
ABTAbbott Laboratories	18.9×	Within its usual range	38
BAXBaxter International	16.4×	Within its usual range	54
BSXBoston Scientific	14.4×	Historically low	2
DXCMDexcom	21.9×	Historically low	3
EWEdwards Lifesciences	30.0×	Within its usual range	42

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on GMED

No articles about GMED yet. How valuation percentiles work

Loading peers and related research…

About this history

What is GMED's current EV/EBITDA?: GMED's EV/EBITDA of 11.5x is lower than 97% of its weekly readings over the last five years.
What is GMED's five-year median EV/EBITDA?: 21.4x. Half of GMED's weekly readings over the last five years were higher and half were lower. This page has 712 weekly readings, from Mar 4, 2013 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares GMED only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.